Svoronos Dawninsider trades

In SEC Form 4 filings, Svoronos Dawn is listed as Director of Xenon Pharmaceuticals Inc. (XENE). Svoronos Dawn reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.

Companies and roles

Company	Role	Transactions	Last filed
XENEXenon Pharmaceuticals Inc.	Director	2	Sep 3

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-03

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
XENEXenon Pharmaceuticals Inc.	Sep 1	Sep 3	M	5,144	$8.15	$41,924	31,373	No	Form 4
XENEXenon Pharmaceuticals Inc.	Sep 1	Sep 3	M · derivative	5,144	$8.15	$41,924	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.